PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Prochlorperazine ×

UPDATED
Actualizaciones regulatorias
12 sept 2026•1 min de lectura
FDA Approves PROCHLORPERAZINE EDISYLATE Injection (ANDA212257)
The FDA has approved the ANDA212257 application for PROCHLORPERAZINE EDISYLATE injectable, manufactured by Somerset Therapeutics, for intramuscular and intravenous use.
UPDATED
Actualizaciones regulatorias
31 ago 2026•1 min de lectura
FDA ANDA089606: Watson Labs' PROCHLORPERAZINE EDISYLATE Injection Discontinued
The FDA’s ANDA089606 filing for Watson Labs’ prochlorperazine edisylate injectable is listed as discontinued, detailing route, dosage form, and active ingredient.